Trial Profile
To Evaluate the Long Term Safety of Latanoprost Treatment in Pediatric Populations
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2019
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- 19 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management